Company Filing History:
Years Active: 2004-2008
Title: The Innovative Contributions of Pablo Sarobe
Introduction
Pablo Sarobe is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of immunology, particularly in the development of vaccines for Hepatitis C virus (HCV). With a total of 3 patents to his name, Sarobe's work is pivotal in advancing medical science and improving public health.
Latest Patents
Sarobe's latest patents include innovative approaches to HCV peptide immunogens and vaccines. One of his patents provides an isolated peptide with the amino acid sequence DLMGYIPAV, along with an isolated HCV core polypeptide featuring an L→A substitution at amino acid position 139. Additionally, he has developed methods for producing an immune response in subjects, which can aid in treating or preventing HCV infection. These patents also encompass nucleic acids that encode the peptides and polypeptides, as well as vectors and cells that incorporate these innovations.
Career Highlights
Pablo Sarobe is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to focus on groundbreaking research that addresses critical health challenges. His contributions have been recognized within the scientific community, underscoring his role as a leading inventor in the field.
Collaborations
Sarobe has collaborated with esteemed colleagues such as Jay A Berzofsky and Stephen M Feinstone. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.
Conclusion
Pablo Sarobe's innovative work in the development of HCV vaccines and immunogens highlights his significant contributions to medical science. His patents reflect a commitment to improving health outcomes and advancing our understanding of viral infections.